Teva Pharmaceuticals agrees to pay $225 million fine to settle price-fixing charges

South Africa News News

Teva Pharmaceuticals agrees to pay $225 million fine to settle price-fixing charges
South Africa Latest News,South Africa Headlines
  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 22 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 12%
  • Publisher: 97%

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd. said Monday that it has reached an agreement with the U.S. Department of...

Teva Pharmaceuticals, a U.S. affiliate of Teva Pharmaceutical Industries Ltd.

said Monday that it has reached an agreement with the U.S. Department of Justice to settle criminal price-fixing charges brought against the company in 2020. Under the deferred prosecution agreement, Teva will pay a fine of $225 million over five years, donate $50 million worth of two generic products to humanitarian organizations, and divest an additional generic product to a third-party buyer, the company said in a release.

We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

MarketWatch /  🏆 3. in US

South Africa Latest News, South Africa Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Teva to pay $225 million in fines and divest generic drug to resolve price-fixing chargesTeva to pay $225 million in fines and divest generic drug to resolve price-fixing chargesIt's the latest resolution in a string of cases related to price-fixing, referring to competitors banding together to artificially set the price of a product.
Read more »

Maiden Pharmaceuticals: Fury in The Gambia a year after cough syrup deathsMaiden Pharmaceuticals: Fury in The Gambia a year after cough syrup deathsGrieving parents say regulators in both India and The Gambia failed their young children.
Read more »

Regeneron shares climb after FDA approval of macular degeneration treatmentRegeneron shares climb after FDA approval of macular degeneration treatmentShares of Regeneron Pharmaceuticals Inc. gained 1.4% premarket on Monday after the company said late Friday that the U.S. Food and Drug Administration had...
Read more »

Redwire and Sierra team up to make drugs in space on inflatable habitat’s first missionRedwire and Sierra team up to make drugs in space on inflatable habitat’s first missionBiological and pharmaceutical research and production is seen as a key customer market for microgravity platforms in space.
Read more »

People Are Sharing Things That Will Instantly Ruin A Burger, And I Absolutely AgreePeople Are Sharing Things That Will Instantly Ruin A Burger, And I Absolutely Agree'Egg on a burger just kinda grosses me out.'
Read more »



Render Time: 2025-02-28 07:17:09